Shares of GE Aerospace soared to levels not seen in nearly two decades on Thursday, after the maker of engines used by airlines and the military provided an upbeat earnings outlook for 2025 and ...

These results strongly indicate that ongoing, chronic treatment with QRX003 is necessary for a continued positive clinical outcome in Netherton Syndrome patients. Table 1: First Patient Data from ...

As the first week of the new Administration concludes, the outlook for the commercial aerospace industry is a mixture of positives and negatives. Aircraft demand continues to be unrelenting as the ...

A bespoke furniture workshop has been given a £9,000 boost to help grow the business. Black Pear Bespoke, based in Netherton, near Evesham, has received the funding from First Enterprise under the ...

It’s amazing what can happen when there’s money to be made. Peter Lucas is a veteran political reporter. He is the author of three books on Albania, including “The OSS in World War II ...

Early in his presidency, President Donald Trump implemented a series of executive orders and actions, including appointing Andrea Lucas as acting chair of the U.S. Equal Employment Opportunity ...

Stark Aerospace, a US-based missile systems and aerial weapons manufacturer contracted with the US Military and the Department of Defense (DoD), has been claimed by the INC ransom group. The ...

Adjusted revenue was $9.9 billion. The company, known as GE Aerospace, also announced plans to repurchase $7 billion of stock in 2025 and increase the dividend by 30%.

(Reuters) - GE Aerospace on Thursday forecast stronger profit in 2025, saying it is better prepared to meet jet engine demand with progress in resolving supply chain issues that had hobbled ...

GE Aerospace easily topped Wall Street expectations and posted solid year-over-year growth. The company boosted its dividend and announced a new share repurchase plan. GE Aerospace is benefitting ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.